Managing cytokine release syndrome in relapsed/refractory multiple myeloma: experience with teclistamab in the MajesTEC-1 study

被引：0

作者：

Catamero, Donna ^{[1
]}

Benito, Patricia Blazquez ^{[2
]}

Shenoy, Samantha ^{[3
]}

Chastain, Katherine ^{[4
]}

Kruyswijk, Sandy ^{[5
]}

机构：

[1] Mt Sinai Hlth Syst, New York, NY USA

[2] Univ Hosp Salamanca, Salamanca, Spain

[3] Univ Calif San Francisco, San Francisco, CA USA

[4] Janssen Res & Dev, Raritan, NJ USA

[5] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NSP-05

引用

页码：S315 / S316

页数：2

共 50 条

[21] Clinical Outcomes of Teclistamab among MajesTEC-1 Eligible and Ineligible Population in the Real-World Setting for the Treatment of Relapsed/Refractory Multiple Myeloma
Tan, Carlyn
Derkach, Andriy
Maclachlan, Kylee
Hultcrantz, Malin
Hassoun, Hani
Mailankody, Sham
Shah, Urvi
Rajeeve, Sridevi
Hashmi, Hamza
Shah, Gunjan
Scordo, Michael
Chung, David
Landau, Heather
Giralt, Sergio
Lesokhin, Alexander
Korde, Neha
Lin, Dee
Wu, Bingcao
Fowler, Jessica
Fernandez, Mariana
Kim, Nina
Doyle, Margaret
Hester, Laura
Orozco, Jennifer
Usmani, Saad
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S91 - S92
[22] Long-term follow-up from the phase 1/2 MajesTEC-1 trial of teclistamab in patients with relapsed/refractory multiple myeloma
Garfall, Alfred L.
Nooka, Ajay K.
van de Donk, Niels W. C. J.
Moreau, Philippe
Bhutani, Manisha
Oriol, Albert
Martin, Thomas G.
Rosinol, Laura
Mateos, Maria-Victoria
Bahlis, Nizar J.
Popat, Rakesh
Besemer, Britta
Martinez-Lopez, Joaquin
Krishnan, Amrita Y.
Delforge, Michel
Huang, Lin
Vishwamitra, Deeksha
Stephenson, Tara
Chastain, Katherine
Sidana, Surbhi
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[23] Long-Term Follow-Up From the Phase 1/2 MajesTEC-1 Trial of Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
Garfall, Alfred L.
Nooka, Ajay K.
van de Donk, Niels W. C. J.
Moreau, Philippe
Bhutani, Manisha
Oriol, Albert
Martin, Thomas G.
Rosinol, Laura
Mateos, Maria-Victoria
Bahlis, Nizar
Popat, Rakesh
Besemer, Britta
Martinez-Lopez, Joaquin
Krishnan, Amrita Y.
Delforge, Michel
Huang, Lin
Vishwamitra, Deeksha
Stephenson, Tara
Chastain, Katherine
Sidana, Surbhi
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S548 - S548
[24] Long-Term Follow-Up From the Phase 1/2 MajesTEC-1 Trial of Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma
Popat, Rakesh
Nooka, Ajay
van de donk, Niels
Moreau, Philippe
Bhutani, Manisha
Oriol, Albert
Martin, Thomas
Rosinol, Laura
Mateos Manteca, Maria-Victoria
Bahlis, Nizar J.
Garfall, Alfred
Besemer, Britta
Martinez-Lopez, Joaquin
Krishnan, Amrita
Delforge, Michel
Huang, Lin
Vishwamitra, Deeksha
Stephenson, Tara
Chastain, Katherine
Sidana, Surbhi
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S80 - S80
[25] Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 study (vol 130, pg 886, 2024)
Nooka, A. K.
Rodriguez, C.
Mateos, M., V
CANCER, 2024, 130 (17) : 3046 - 3046
[26] Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study
Martin, Thomas G.
Moreau, Philippe
Usmani, Saad Z.
Garfall, Alfred
Mateos, Maria -Victoria
San-Miguel, Jesus F.
Oriol, Albert
Nooka, Ajay K.
Rosinol, Laura
Chari, Ajai
Karlin, Lionel
Krishnan, Amrita
Bahlis, Nizar
Popat, Rakesh
Besemer, Britta
Martinez-Lopez, Joaquin
Delforge, Michel
Trancucci, Danielle
Pei, Lixia
Kobos, Rachel
Fastenau, John
Gries, Katharine S.
van de Donk, Niels W. C. J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (03): : 194 - 202
[27] Teclistamab in Relapsed or Refractory Multiple Myeloma
Hindie, Elif
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (18): : 1721 - 1723
[28] Teclistamab in Relapsed or Refractory Multiple Myeloma
Moreau, Philippe
Garfall, Alfred L.
van de Donk, Niels W. C. J.
Nahi, Hareth
San-Miguel, Jesus F.
Oriol, Albert
Nooka, Ajay K.
Martin, Thomas
Rosinol, Laura
Chari, Ajai
Karlin, Lionel
Benboubker, Lotfi
Mateos, Maria-Victoria
Bahlis, Nizar
Popat, Rakesh
Besemer, Britta
Martinez-Lopez, Joaquin
Sidana, Surbhi
Delforge, Michel
Pei, Lixia
Trancucci, Danielle
Verona, Raluca
Girgis, Suzette
Lin, Shun X. W.
Olyslager, Yunsi
Jaffe, Mindy
Uhlar, Clarissa
Stephenson, Tara
Van Rampelbergh, Rian
Banerjee, Arnob
Goldberg, Jenna D.
Kobos, Rachel
Krishnan, Amrita
Usmani, Saad Z.
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (06): : 495 - 505
[29] Efficacy and Safety of Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) With High-Risk (HR) Features: a Subgroup Analysis From the Phase 1/2 MajesTEC-1 Study
Costa, Luciano J.
Bahlis, Nizar J.
Usmani, Saad Z.
van de Donk, Niels W. C. J.
Nooka, Ajay K.
Perrot, Aurore
Qi, Keqin
Hodin, Caroline
Uhlar, Clarissa
Zuppa, Athena
Chastain, Katherine
Doyle, Margaret
Maria-Victoria, Mateos
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S546 - S547
[30] Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
Hamadeh, Issam
Shekarkhand, Tala
Rueda, Colin
Firestone, Ross
Wang, Alice
Korde, Neha
Hultcrantz, Malin
Lesokhin, Alexander
Mailankody, Sham
Hassoun, Hani
Shah, Urvi
Maclachlan, Kylee
Patel, Dhwani
Shah, Gunjan
Scordo, Michael
Lahoud, Oscar
Chung, David
Landau, Heather
Giralt, Sergio
Usmani, Saad
Tan, Carlyn Rose
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S40 - S40

← 1 2 3 4 5 →